These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21685299)

  • 1. Late-age onset systemic sclerosis.
    Manno RL; Wigley FM; Gelber AC; Hummers LK
    J Rheumatol; 2011 Jul; 38(7):1317-25. PubMed ID: 21685299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-age onset systemic sclerosis-clinical and serological characteristics.
    Wielosz E; Wiąk-Walerowicz K; Łyś E; Lipska A; Dryglewska M; Majdan M
    Clin Rheumatol; 2024 Aug; 43(8):2565-2572. PubMed ID: 38904748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
    Scalapino K; Arkachaisri T; Lucas M; Fertig N; Helfrich DJ; Londino AV; Steen VD; Medsger TA
    J Rheumatol; 2006 May; 33(5):1004-13. PubMed ID: 16583463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
    Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
    Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis.
    Krikeerati T; Pussadhamma B; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Foocharoen C
    Mod Rheumatol; 2021 May; 31(3):649-656. PubMed ID: 32924684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary?
    Foocharoen C; Mahakkanukrauh A; Pussadhamma B; Netwijitpan S; Suwannaroj S; Nanagara R
    J Clin Rheumatol; 2014 Aug; 20(5):268-74. PubMed ID: 25036561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in clinical presentation and incidence of cardiopulmonary involvement in late-onset versus early-onset systemic sclerosis: inception cohort study.
    Wangkaew S; Phiriyakrit P; Sawangduan V; Prasertwittayakij N; Euathrongchit J
    Int J Rheum Dis; 2018 May; 21(5):1082-1092. PubMed ID: 29673120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study.
    Wangkaew S; Pota P; Prasertwittayakij N; Phrommintikul A
    Clin Rheumatol; 2021 Mar; 40(3):973-980. PubMed ID: 32683661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis.
    Kumar U; Ramteke R; Yadav R; Ramam M; Handa R; Kumar A
    J Assoc Physicians India; 2008 Jun; 56():413-7. PubMed ID: 18822619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
    Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
    Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
    Yaqub A; Chung L
    Curr Rheumatol Rep; 2013 Jan; 15(1):302. PubMed ID: 23292818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
    Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
    Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.